Evidence map›Paper›PMID 27864179›Full record

ArticleApplied and environmental microbiology2017

Prevalence of Antibiotic Resistance Genes among Human Gut-Derived Bifidobacteria.

Sabrina Duranti, Gabriele Andrea Lugli, Leonardo Mancabelli, Francesca Turroni, Christian Milani, Marta Mangifesta, Chiara Ferrario, Rosaria Anzalone, Alice Viappiani, Douwe van Sinderen and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Insights into toxin-antitoxin systems in the genusApplied and environmental microbiology · 2025
    Review
  6. Article
  7. Abundance ofmSphere · 2025
    Article
  8. Antibiotic Resistance inMicroorganisms · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Sabrina DurantiLaboratory of Probiogenomics, Department of Life Sciences, University of Parma, Parma, Italy.
Gabriele Andrea LugliLaboratory of Probiogenomics, Department of Life Sciences, University of Parma, Parma, Italy.
Leonardo MancabelliLaboratory of Probiogenomics, Department of Life Sciences, University of Parma, Parma, Italy.
Francesca TurroniLaboratory of Probiogenomics, Department of Life Sciences, University of Parma, Parma, Italy.
Christian MilaniLaboratory of Probiogenomics, Department of Life Sciences, University of Parma, Parma, Italy.
Marta MangifestaGenProbio srl, Parma, Italy.
Chiara FerrarioLaboratory of Probiogenomics, Department of Life Sciences, University of Parma, Parma, Italy.
Rosaria AnzaloneLaboratory of Probiogenomics, Department of Life Sciences, University of Parma, Parma, Italy.
Alice ViappianiGenProbio srl, Parma, Italy.
Douwe van SinderenAPC Microbiome Institute and School of Microbiology, National University of Ireland, Cork, Ireland.
Marco VenturaLaboratory of Probiogenomics, Department of Life Sciences, University of Parma, Parma, Italy marco.ventura@unipr.it.
University of Parma · ITAPC Microbiome Institute · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The microbiota of the human gastrointestinal tract (GIT) may regularly be exposed to antibiotics, which are used to prevent and treat infectious diseases caused by bacteria and fungi. Bacterial communities of the gut retain a reservoir of antibiotic resistance (AR) genes, and antibiotic therapy thus positively selects for those microorganisms that harbor such genetic features, causing microbiota modulation. During the first months following birth, bifidobacteria represent some of the most dominant components of the human gut microbiota, although little is known about their AR gene complement (or resistome). In the current study, we assessed the resistome of the Bifidobacterium genus based on phenotypic and genotypic data of members that represent all currently recognized bifidobacterial (sub)species. Moreover, a comparison between the bifidobacterial resistome and gut metagenome data sets from adults and infants shows that the bifidobacterial community present at the first week following birth possesses a reduced AR arsenal compared to that present in the infant bifidobacterial population in subsequent weeks of the first year of life. Our findings reinforce the concept that the early infant gut microbiota is more susceptible to disturbances by antibiotic treatment than the gut microbiota developed at a later life stage. IMPORTANCE: The spread of resistance to antibiotics among bacterial communities has represented a major concern since their discovery in the last century. The risk of genetic transfer of resistance genes between microorganisms has been extensively investigated due to its relevance to human health. In contrast, there is only limited information available on antibiotic resistance among human gut commensal microorganisms such as bifidobacteria, which are widely exploited by the food industry as health-promoting microorganisms or probiotic ingredients. In the current study, we explored the occurrence of antibiotic resistance genes in the genomes of bifidobacteria and evaluated their genetic mobility to other human gut commensal microorganisms.

Indexed as

Anti-Bacterial AgentsBifidobacteriumDrug Resistance, MicrobialGastrointestinal TractGenes, BacterialHumansAnti-Bacterial Agentsantibiotic resistance genesbifidobacteriagut microbiomeshuman gutresistomes

Identifiers

PMID27864179
PMCPMC5244288
OpenAlexW2550095445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.